Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Sarcomatoid Carcinoma”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Testing effectiveness (Phase 2)Study completedNCT06446570
What this trial is testing

Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma

Who this might be right for
HNSCCHead and Neck Neoplasms
Seoul National University Hospital 18
Testing effectiveness (Phase 2)UnknownNCT02897479
What this trial is testing

A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer

Who this might be right for
Lung Sarcomatoid Carcinoma
Hutchison Medipharma Limited 76
Testing effectiveness (Phase 2)Looking for participantsNCT04888429
What this trial is testing

Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma

Who this might be right for
Sarcomatoid Carcinoma of Lung
Qian Chu 28
Early research (Phase 1)Ended earlyNCT02029690
What this trial is testing

Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Who this might be right for
Pleural Mesothelioma Malignant AdvancedPeritoneal Mesothelioma Malignant AdvancedNon-squamous Non-small Cell Lung Carcinoma+4 more
Polaris Group 85
Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Testing effectiveness (Phase 2)Study completedNCT04224337
What this trial is testing

Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Seoul National University Hospital 16
Not applicableUnknownNCT04215913
What this trial is testing

Integrative Analysis of Pulmonary Sarcomatoid Carcinoma (PSC)

Who this might be right for
Lung Cancer
Shanghai 10th People's Hospital 300
Not applicableStudy completedNCT05337163
What this trial is testing

Clinical Trial of Sputum DNA Testing for Lung Cancer in China

Who this might be right for
Lung CancerSmall Cell Lung CancerNon-Small Cell Lung Cancer+13 more
Creative Biosciences (Guangzhou) Co., Ltd. 1,564
Testing effectiveness (Phase 2)UnknownNCT04725448
What this trial is testing

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

Who this might be right for
Pulmonary Sarcomatoid CarcinomaNon-small Cell Lung CancerLung Diseases+1 more
Sichuan Cancer Hospital and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT03022500
What this trial is testing

Pulmonary sarcomatoid_MEDI4736+Treme

Who this might be right for
Durvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLC
Seoul National University Hospital 32